age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71.461
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 0
| 13,818
| 9,869.6172
| 8,757.28906
| 14.5
|
white
| 22.796875
| 25
| 0.802979
| 0.736938
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 10
| 73
| 8.699219
| 60
| 24
| 36.29688
| 128.5625
| 4.399414
| 1.799805
| 1.199951
| 139
| 7.469727
| null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 1,655
| 0
|
70.15997
|
male
| 1
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 55
| 3,284
| 2,367.4102
| 2,257.75
| 16
|
white
| 18.898438
| 26
| 0.525879
| 0.326965
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 113
| 10.298828
| 109
| 26
| 38.29688
| 414.8125
| null | null | 1.099854
| 147
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.446777
| 3
| 1
|
83.33496
|
male
| 0
| 200
|
Coma
|
Coma
| 2
| 17
|
$11-$25k
| 26
| 344,708
| 266,838.25
| 247,714
| 33
|
white
| 29.796875
| 43
| 0.079987
| 0.044998
| 12
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 103
| 103
| 31.796875
| 118
| 38
| 39.19531
| 143.3125
| null | null | 1.399902
| 144
| 7.429688
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 226
| 1
|
65.23499
|
male
| 0
| 24
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 14,680
| 11,844.125
| 10,716.4297
| 9
|
white
| 19.398438
| 41
| 0.869995
| 0.784912
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 82
| 16.597656
| 126
| 26
| 36.09375
| 196
| 4.899414
| 0.5
| 0.899902
| 134
| 7.439453
| null | null | null | 3
| 4
|
<2 mo. follow-up
| 4
| 26
| 1
|
68.74695
|
male
| 0
| 17
|
Coma
|
Coma
| 1
| 6
|
under $11k
| 55
| 13,519
| 10,571.8984
| 8,644.44531
| 13.333328
|
white
| 18.5
| 35
| 0.555908
| 0.487
| 1
| 1
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 1
| 131
| 12.798828
| 71
| 24
| 39
| null | 5.099609
| 0.599976
| 2
| 136
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
67.67694
|
female
| 0
| 91
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 259,766
| 208,491.375
| 194,043.875
| 22.75
|
white
| 28.699219
| 36
| 0.613892
| 0.507935
| 52
| 1
| 0
|
no
| 0.3
| 0.05
|
dnr after sadm
| 38
| 63
| 10.5
| 124
| 10
| 36.29688
| 440
| null | null | 1.599854
| 126
| 7.519531
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 112
| 1
|
72.68195
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 12
|
under $11k
| 0
| 2,763
| 2,216.8535
| 1,728.75977
| 10
|
white
| 21.199219
| 35
| 0.823975
| 0.712891
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 1
| 62
| 7.799805
| 74
| 32
| 36.09375
| 357.125
| null | 0.599976
| 1.799805
| 131
| 7.399414
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 666
| 1
|
71.15094
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 2,546
| 2,086.7031
| 1,616.51953
| 17
|
white
| 29.796875
| 45
| 0.684937
| 0.517944
| 1
| 0
| 1
|
no
| 0.8
| 0.5
|
no dnr
| 4
| 107
| 7.599609
| 96
| 36
| 35.79688
| 370
| 3.399902
| 0.399963
| 3.799805
| 129
| 7.519531
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 425
| 1
|
80.98297
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 8,698
| 7,073.2539
| 6,178.77734
| 21
|
white
| 18.199219
| 32
| 0.803955
| 0.682983
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 98
| 10.798828
| 73
| 40
| 35.79688
| 274.0625
| 4
| 1
| 1.5
| 136
| 7.369141
| null | null | null | 3
| null | null | 2.511099
| 151
| 1
|
70.79297
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 6
| null | 0
| 2,528
| 1,650.9307
| 1,010.27979
| 14
|
white
| 13.898438
| 16
| 0.75293
| 0.495972
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 3
| 103
| 4.699219
| 101
| 18
| 36.09375
| null | 3.799805
| 0.399963
| 0.899902
| 137
| null | null | null | null | null | null | null | 1.940186
| 386
| 1
|
42.50497
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 5,223
| 3,816.0859
| 2,861.12891
| 15
|
white
| 31.199219
| 45
| 0.414978
| 0.112991
| 1
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 107
| 24.398438
| 140
| 28
| 36.09375
| 214.28125
| 3
| 0.599976
| 0.899902
| 135
| 7.489258
| null | null | null | 2
| 3
|
<2 mo. follow-up
| 3
| 20
| 1
|
75.06897
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 1,650
| 1,356.8184
| 1,012.84961
| 19
|
white
| 20.898438
| 33
| 0.81897
| 0.704956
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 107
| 9.298828
| 60
| 24
| 35.69531
| 304.75
| 3.899902
| 1.099854
| 2.699707
| 141
| 7.479492
| null | null | null | null | null | null | 2.020996
| 1,641
| 0
|
66.30298
|
female
| 1
| 68
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 13
|
under $11k
| 100
| 211,130
| 158,519.25
| 138,657.875
| 31.25
|
white
| 22
| 32
| 0.32196
| 0.207977
| 30
| 1
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 68
| 67
| 12.298828
| 104
| 10
| 38.29688
| 310
| null | null | 2.399902
| 139
| 7.399414
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 68
| 1
|
64.91394
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 0
| 3,954
| 3,177.4356
| 3,081.94922
| 10
|
white
| 17.097656
| 40
| 0.890991
| 0.817993
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 119
| 13.398438
| 69
| 30
| 37.89844
| 155.53125
| 4.099609
| 0.299988
| 1.5
| 139
| 7.329102
| null | null | null | null | 1
| null | 1
| 1,312
| 1
|
76.06598
|
female
| 0
| 25
|
Coma
|
Coma
| 0
| 8
| null | 61
| 23,227
| 17,351.5156
| 15,446.7266
| 21.25
|
white
| 23.296875
| 41
| 0.312988
| 0.240997
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 1
| 114
| 12.298828
| 75
| 32
| 39.09375
| 151.40625
| 4.599609
| 0.5
| 0.799927
| 131
| 7.339844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,639
| 0
|
84.50098
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
| null | 0
| 3,319
| 2,655.6875
| 2,375.48828
| 4
|
white
| 14.798828
| 23
| 0.860962
| 0.769897
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 105
| 13.099609
| 69
| 20
| 36.19531
| 344.4375
| 3.699707
| 0.199982
| 0.899902
| 141
| 7.479492
| null | null | null | 1
| null | null | 1.1669
| 833
| 1
|
62.35498
|
male
| 0
| 27
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 57,132
| 47,951.4062
| 49,411.9062
| 28.75
|
white
| 32.195313
| 40
| 0.678955
| 0.508911
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 20
| 52
| 6.399414
| 148
| 31
| 36.39844
| 210
| null | null | 0.599976
| 130
| 7.369141
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 41
| 1
|
71.07196
|
male
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 54,979
| 41,784.8125
| 35,870.5625
| 34.25
|
white
| 28.097656
| 51
| 0.652954
| 0.553955
| 1
| 1
| 0
|
yes
| 0.25
| 0.015625
|
no dnr
| 41
| 57
| 15.699219
| 102
| 12
| 38.09375
| 178
| 2.5
| 1.799805
| 2.699707
| 139
| 7.339844
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 1,631
| 0
|
50.51599
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 5,910
| 4,305.207
| 3,984.17969
| 20
|
white
| 20.398438
| 31
| 0.885986
| 0.845947
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 6
| 74
| 19.699219
| 110
| 24
| 36.59375
| 261.875
| 3.299805
| 0.5
| 1.399902
| 139
| 7.429688
| null | null | null | 5
| 4
|
adl>=4 (>=5 if sur)
| 4
| 1,633
| 0
|
79.99695
|
male
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
| null | 0
| 65,864
| 41,325.25
| 66,365
| 38.75
|
white
| 27
| 24
| 0.659912
| 0.56189
| 3
| 0
| 0
|
no
| 0.35
| 0.35
|
dnr after sadm
| 18
| 140
| 12.199219
| 138
| 15
| 38.59375
| 224.4375
| null | null | 0.799927
| 125
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
56.99399
|
male
| 1
| 24
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 2,625
| 34,046.4062
| 32,203.25
| 24.333328
|
white
| 16.898438
| 20
| 0.727905
| 0.455994
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 7
| 51
| 5.199219
| 74
| 24
| 36.69531
| null | 3.699707
| 0.299988
| 0.899902
| 136
| null | null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 24
| 1
|
70.09399
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 0
| 6,099
| 5,066.2188
| 4,108.25781
| 11.5
|
white
| 11.199219
| 26
| 0.921997
| 0.866943
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 8
| 80
| 10.798828
| 77
| 20
| 36.39844
| 309.5
| 4.399414
| 0.399963
| 1.599854
| 139
| 7.439453
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,388
| 1
|
84.30396
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 9
| 29,884
| 21,718.8906
| 18,873.1875
| 20
|
white
| 27.699219
| 36
| 0.566895
| 0.454956
| 4
| 0
| 1
|
no
| 0.2
| 0.1
|
dnr after sadm
| 4
| 78
| 5.899414
| 71
| 15
| 36.5
| 93.32812
| null | null | 2
| 138
| 7.379883
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 29
| 1
|
79.69897
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 9,814
| 8,019.625
| 7,759.37891
| 11
|
white
| 19.898438
| 34
| 0.735962
| 0.585938
| 1
| 0
| 0
|
yes
| 0.7
| 0.5
|
dnr after sadm
| 1
| 110
| 21.199219
| 118
| 28
| 35.59375
| 304.75
| 4.199219
| 0.399963
| 1.199951
| 139
| 7.459961
| null | null | null | null | null | null | 4.431641
| 71
| 1
|
51.27197
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 2,531
| 2,096.4453
| 1,889.21973
| 6
|
white
| 11.199219
| 11
| 0.897949
| 0.764893
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
no dnr
| 5
| 75
| null | 89
| 22
| 36.19531
| null | 3.899902
| 0.299988
| 0.799927
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 338
| 1
|
64.62695
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 5,192
| 4,223.6055
| 3,330.64844
| 13
|
white
| 16.097656
| 28
| 0.900879
| 0.833984
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 8
| 63
| 11.699219
| 73
| 32
| 36.39844
| 200
| 4.199219
| 0.5
| 0.699951
| 134
| 7.299805
| null | null | null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 1,531
| 1
|
70.21796
|
female
| 0
| 8
|
Coma
|
Coma
| 2
| 8
|
under $11k
| 44
| 9,225
| 7,920.3242
| 8,289.5625
| 13.5
|
white
| 17.398438
| 17
| 0.619995
| 0.557983
| 1
| 0
| 1
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 115
| 6.399414
| 60
| 24
| 35.59375
| null | 3.399902
| 0.299988
| 0.899902
| 143
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 18
| 1
|
76.22699
|
male
| 1
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 9
| 7,085
| 4,792.3516
| 4,949.99609
| 26
|
white
| 17.5
| 23
| 0.819946
| 0.706909
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 5
| 85
| 13.599609
| 138
| 10
| 38.09375
| 170
| 4.299805
| 0.299988
| 1.199951
| 139
| 7.399414
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 5
| 1
|
76.159
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 8
|
$11-$25k
| 0
| 3,508
| 2,545.4492
| 2,052.04883
| 11
|
white
| 19
| 25
| 0.636963
| 0.327942
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 67
| 18.597656
| 66
| 24
| 36.29688
| null | null | null | 1
| 132
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 257
| 1
|
64.71698
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
>$50k
| 0
| 2,744
| 2,202.8066
| 1,636.71973
| 18
|
white
| 26.199219
| 33
| 0.782959
| 0.651978
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 67
| 10
| 57
| 24
| 36.09375
| null | 3.599609
| 1.799805
| 2.399902
| 129
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 38
| 1
|
83.474
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 4,876
| 4,143.4727
| 3,467.36914
| 7
|
white
| 18.097656
| 20
| 0.78894
| 0.661987
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 8
| 106
| 10
| 69
| 24
| 35.39844
| null | null | null | 1.299805
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,622
| 0
|
44.34799
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 58,947
| 62,907.3125
| 65,362.875
| 20
|
white
| 23.796875
| 18
| 0.755981
| 0.5
| 1
| 0
| 0
|
metastatic
| 0.49
| 0.39
|
dnr after sadm
| 6
| 101
| 5.5
| 132
| 20
| 38.19531
| null | null | null | 0.599976
| 128
| null | null | null | null | 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 118
| 1
|
57.36099
|
male
| 1
| 6
|
Coma
|
Coma
| 2
| null | null | 44
| 5,527
| 4,044.2441
| 4,410.9375
| 23
|
white
| 18.296875
| 19
| 0.634888
| 0.573975
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 1
| 72
| 11.099609
| 101
| 24
| 38
| null | null | null | 1.399902
| 148
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.000488
| 6
| 1
|
78.89899
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 13,276
| 8,470.8203
| 4,400.08984
| 16.5
|
white
| 13.699219
| 18
| 0.834961
| 0.639893
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.6
|
no dnr
| 9
| 68
| 7.299805
| 67
| 16
| 36.79688
| null | 3.599609
| 0.399963
| 0.699951
| 141
| null | null | null | null | null | null | null | 2.405762
| 807
| 1
|
60.76099
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 20
| null | 26
| 10,343
| 8,276
| 6,551.45703
| 12.5
|
white
| 25.699219
| 44
| 0.718994
| 0.632935
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 9
| 122
| 12.798828
| 108
| 28
| 36.29688
| 525.875
| 2.5
| 0.899902
| 11.5
| 132
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 176
| 1
|
58.54099
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 43,636
| 37,861.7188
| 31,906.5312
| 17.333328
|
white
| 19.296875
| 34
| 0.777954
| 0.705933
| 11
| 0
| 0
|
yes
| null | null |
no dnr
| 23
| 103
| 34.398438
| 98
| 24
| 37.89844
| 219.96875
| null | null | 1.5
| 145
| 7.419922
| null | null | null | null | null | null | 1.980469
| 1,618
| 0
|
67.39996
|
male
| 1
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 20
|
under $11k
| 0
| 6,910
| 4,843.6016
| 4,028.19922
| 13.5
|
white
| 41.59375
| 46
| 0.311951
| 0.130981
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 2
| 115
| 35.296875
| 114
| 32
| 36.09375
| 69.375
| 3.299805
| 0.699951
| 0.5
| 128
| 7.269531
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
65.57397
|
female
| 1
| 8
|
Coma
|
Coma
| 4
| 12
|
under $11k
| 100
| 16,053
| 11,305.8203
| 11,408.7734
| 26.5
|
white
| 28.796875
| 28
| 0.046997
| 0.023998
| 8
| 1
| 1
|
no
| 0.1
| 0.001
|
no dnr
| 8
| 44
| 12.199219
| 78
| 8
| 38
| 170
| 2.699707
| 0.299988
| 0.899902
| 131
| 7.449219
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 8
| 1
|
79.10199
|
female
| 0
| 24
|
Colon Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 12,781
| 11,217.625
| 9,313.01562
| 12.333328
|
white
| 17.097656
| 33
| 0.78894
| 0.554932
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 107
| 8.798828
| 84
| 28
| 36.59375
| 342.8125
| 3.399902
| 0.599976
| 1.199951
| 134
| 7.469727
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 37
| 1
|
68.383
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
|
$11-$25k
| 0
| 5,863
| 4,946.7148
| 4,396.44922
| 6
|
white
| 24.699219
| 47
| 0.789917
| 0.66394
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 1
| 53
| 13
| 70
| 24
| 36.79688
| 214.8125
| 4
| 0.799927
| 2.299805
| 130
| 7.419922
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 64
| 1
|
78.95697
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 4,206
| 3,423.6699
| 2,941.35938
| 15
|
white
| 20.699219
| 31
| 0.805908
| 0.68689
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 5
| 54
| 5.599609
| 59
| 24
| 36.89844
| null | 3.299805
| 1
| 1.299805
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,610
| 0
|
73.04596
|
female
| 0
| 21
|
Colon Cancer
|
Cancer
| 1
| 14
|
under $11k
| 37
| 10,583
| 9,048.7578
| 8,211.65625
| 7.333332
|
white
| 11.798828
| 17
| 0.781982
| 0.542969
| 1
| 0
| 0
|
metastatic
| 1
| 0.55
|
dnr after sadm
| 15
| 129
| 4.5
| 93
| 16
| 37.89844
| null | 3.799805
| 1.699951
| 1
| 134
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 77
| 1
|
40.39697
|
male
| 1
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 0
| 82,155
| 101,362.375
| 95,366.9375
| 38.333313
|
white
| 34
| 68
| 0.35199
| 0.234985
| 53
| 0
| 0
|
yes
| 0.05
| 0.000125
|
no dnr
| 23
| 64
| 0.099991
| 146
| 34
| 40.09375
| null | 2.899902
| 2.5
| 1.199951
| 133
| null | null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 23
| 1
|
42.133
|
female
| 1
| 75
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 26
| 262,140
| 178,584.375
| 151,271.625
| 42.5
|
white
| 30
| 31
| 0.652954
| 0.553955
| 9
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 74
| 103
| 15.5
| 120
| 12
| 39.69531
| 103.32812
| 2.399902
| 0.5
| 0.599976
| 137
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 75
| 1
|
74.95697
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 15
|
$25-$50k
| 9
| 3,143
| 2,138.3906
| 1,401.7793
| 10
|
white
| 13.099609
| 20
| 0.72998
| 0.457947
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 4
| 119
| 14.599609
| 87
| 20
| 36.09375
| null | 3.799805
| 0.299988
| 1.199951
| 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.061523
| 52
| 1
|
73.04297
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 8,504
| 6,603.0742
| 5,872.08984
| 17
|
white
| 17.796875
| 27
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 107
| 19.296875
| 65
| 28
| 36
| 216
| 3.799805
| 0.599976
| 1.099854
| 138
| 7.389648
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,164
| 1
|
80.78894
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 7
|
under $11k
| 0
| 3,369
| 2,766.6016
| 2,815.76953
| 14
|
white
| 21.699219
| 34
| 0.691895
| 0.526978
| 1
| 0
| 0
|
yes
| 0.5
| 0.1
|
no dnr
| 6
| 70
| 7
| 114
| 28
| 35.69531
| 460
| null | 0.799927
| 1.199951
| 138
| 7.339844
| null | null | null | null | null | null | 3.179199
| 644
| 1
|
78.02295
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 5,563
| 4,325.4375
| 3,838.91992
| 9
|
white
| 14.798828
| 38
| 0.825928
| 0.716919
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 7
| 109
| 6.199219
| 76
| 28
| 36.79688
| 204.75
| 3
| 0.199982
| 0.599976
| 140
| 7.369141
| null | null | null | 2
| 4
|
no(M2 and SIP pres)
| 4
| 1,604
| 0
|
74.25598
|
female
| 0
| 16
|
Colon Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 0
| 7,361
| 6,515.6016
| 6,316.35938
| 7.666664
|
white
| 6.5
| 20
| 0.908936
| 0.789917
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 16
| 104
| 7.299805
| 74
| 24
| 38
| null | 4
| 0.5
| 1.099854
| 136
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 111
| 1
|
71.02295
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 1,851
| 1,514.1279
| 1,188
| 11
|
white
| 18.5
| 22
| 0.853882
| 0.758911
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 4
| 107
| null | 98
| 28
| 36
| 452
| null | null | null | 140
| 7.379883
| null | null | null | null | null | null | 2.083496
| 170
| 1
|
68.44897
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 3,947
| 3,385.7012
| 3,018.31836
| 6
|
white
| 16.296875
| 14
| 0.819946
| 0.611938
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 80
| 10
| 107
| 24
| 38.59375
| null | 3.599609
| 0.5
| 1
| 133
| null | null | null | null | null | null | null | 2.251465
| 70
| 1
|
64.698
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 1,917
| 1,679.8438
| 1,222.37988
| 14
|
white
| 16.796875
| 16
| 0.892944
| 0.819946
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 70
| null | 73
| 16
| 35.39844
| null | null | null | 1.199951
| 140
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.821289
| 1,600
| 0
|
82.99799
|
male
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| null | null | 0
| 2,277
| 1,776.459
| 1,493.75977
| 26
|
white
| 20.398438
| 39
| 0.746948
| 0.601929
| 1
| 1
| 1
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 1
| 106
| 9.298828
| 60
| 40
| 37.89844
| 300
| 3.199707
| 0.899902
| 1.5
| 145
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 6.266602
| 4
| 1
|
54.79498
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 10,684
| 7,769.9062
| 7,832.01953
| 19.5
|
white
| 18.398438
| 22
| 0.91394
| 0.85498
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 11
| 110
| 12.099609
| 76
| 32
| 36.79688
| 193.3125
| null | null | 0.899902
| 140
| 7.379883
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,598
| 0
|
75.09399
|
male
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 9
| 15,305
| 10,673.5938
| 8,756.25
| 33
|
white
| 24.699219
| 41
| 0.455994
| 0.253967
| 1
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 1
| 117
| 12.199219
| 42
| 49
| 36.29688
| null | 3
| 2.699707
| 1.199951
| 136
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 60
| 1
|
57.88098
|
female
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 66,800
| 45,979.0625
| 47,007.7188
| 37
|
white
| 36.398438
| 60
| 0.600952
| 0.493958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 39
| 49
| 7.599609
| 138
| 39
| 39.39844
| 195
| 2.899902
| 4.899414
| 1.599854
| 148
| 7.389648
| null | null | null | null | 1
| null | 1
| 1,596
| 0
|
72.56097
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 3,628
| 3,037.8301
| 2,097.91992
| 6
|
white
| 26.097656
| 53
| 0.748901
| 0.603882
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 1
| 53
| 7.899414
| 74
| 28
| 34.69531
| 545.625
| 4
| 2.899902
| 1.899902
| 139
| 7.339844
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 49
| 1
|
70.26398
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 2
| 8
| null | 0
| 12,682
| 10,659.3516
| 11,444.0547
| 13.5
|
white
| 17
| 14
| 0.807983
| 0.588989
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.25
|
no dnr
| 9
| 60
| 12.898438
| 77
| 20
| 38.69531
| null | 3.299805
| 0.199982
| 0.799927
| 134
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 22
| 1
|
70.66095
|
female
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
| null | 9
| 15,128
| 11,270.9531
| 10,102.7734
| 16.666656
|
white
| 25.597656
| 36
| 0.497986
| 0.380981
| 3
| 0
| 0
|
metastatic
| null | null |
no dnr
| 15
| 142
| 5.899414
| 138
| 16
| 36
| 452
| 3.899902
| 0.5
| 1.899902
| 142
| 7.369141
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,269
| 1
|
74.97595
|
male
| 0
| 22
|
Coma
|
Coma
| 0
| 14
|
>$50k
| 0
| 44,963
| 32,121.5469
| 28,611.6094
| 31.666656
|
white
| 18.199219
| 15
| 0.73291
| 0.68396
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 22
| 117
| 7.199219
| 66
| 24
| 36.79688
| 163
| 4.399414
| 0.599976
| 0.899902
| 138
| 7.429688
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,590
| 0
|
61.61499
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 13
| null | 0
| 2,784
| 2,036.6143
| 1,695.25977
| 3
|
white
| 15.798828
| 10
| 0.738892
| 0.471985
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.6
|
no dnr
| 3
| 100
| null | 93
| 20
| 36.19531
| null | null | null | null | 140
| null | null | null | null | null | null |
<2 mo. follow-up
| 1.985352
| 5
| 1
|
66.97894
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 15
|
under $11k
| 0
| 3,928
| 3,099.3711
| 2,706.92969
| 7
|
white
| 8.699219
| 19
| 0.835938
| 0.640991
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 5
| 111
| 8
| 72
| 20
| 35.19531
| null | 4.299805
| 0.599976
| 1.099854
| 134
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 528
| 1
|
53.91599
|
female
| 0
| 17
|
Coma
|
Coma
| 1
| 11
|
$11-$25k
| 0
| 24,481
| 16,262.6328
| 22,232.1719
| 22.333328
|
white
| 19
| 12
| 0.767944
| 0.723999
| 3
| 0
| 0
|
yes
| 0.8
| 0.8
|
dnr after sadm
| 1
| 119
| 16.296875
| 42
| 10
| 38.39844
| 262.5
| 4.199219
| 0.599976
| 0.799927
| 143
| 7.489258
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,588
| 0
|
47.07498
|
female
| 0
| 57
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 44
| 82,385
| 56,124.2812
| 56,664.5938
| 32
|
white
| 25.398438
| 24
| 0.691895
| 0.526978
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.3
|
no dnr
| 57
| 75
| 12.699219
| 127
| 8
| 38.79688
| 116
| 3.599609
| 0.399963
| 0.899902
| 141
| 7.169922
| null | null | null | null | null | null | 4.09668
| 119
| 1
|
89.54095
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| 14
| null | 100
| 4,136
| 3,253.3594
| 2,923.5293
| 22
|
white
| 31.699219
| 67
| 0.003
| 0.001
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 58
| 9.099609
| 110
| 40
| 38.5
| 140.8125
| 4.5
| 0.799927
| 3
| 143
| 7.169922
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
91.34595
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 20,829
| 13,574.1875
| 13,898.7656
| 41
|
white
| 40.398438
| 57
| 0.213989
| 0.117996
| 3
| 0
| 1
|
no
| 0.3
| 0.3
|
dnr after sadm
| 7
| 47
| 15.599609
| 160
| 9
| 39.69531
| 123.32812
| 2.599609
| 1.399902
| 1.699951
| 133
| 7.429688
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
88.79895
|
male
| 1
| 5
|
Coma
|
Coma
| 1
| 6
|
under $11k
| 100
| 2,583
| 2,126.9863
| 1,623.67969
| 12
|
white
| 19.796875
| 40
| 0.112
| 0.067993
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 61
| 8.199219
| 66
| 10
| 38.79688
| 352.375
| 4.099609
| 1.699951
| 2
| 138
| 7.429688
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 5
| 1
|
78.02295
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
|
$11-$25k
| 0
| 33,443
| 21,901.5781
| 21,580.6875
| 31
|
white
| 34.09375
| 48
| 0.340942
| 0.224976
| 12
| 0
| 0
|
yes
| 0.25
| 0.25
|
no dnr
| 10
| 107
| 0.399963
| 120
| 26
| 36.39844
| 268
| null | null | 0.599976
| 131
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
82.31299
|
male
| 0
| 3
|
Coma
|
Coma
| 0
| 8
|
under $11k
| 100
| 6,698
| 4,614.625
| 4,624.59766
| 57
|
white
| 47
| 51
| 0
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 42
| 15.099609
| 114
| 20
| 35.89844
| 12
| 3
| 0.599976
| 1.399902
| 145
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
63.12097
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 4,309
| 3,033.959
| 3,010.70898
| 11
|
white
| 11
| 16
| 0.81189
| 0.596924
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 5
| 103
| 5.5
| 104
| 22
| 36.29688
| null | 4.199219
| 0.699951
| 0.799927
| 134
| null | null | null | null | null | null | null | 1.967285
| 89
| 1
|
75.88995
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 26
| 4,709
| 3,727.0742
| 3,350.64844
| 11
|
white
| 24.699219
| 47
| 0.636963
| 0.454956
| 1
| 1
| 1
|
no
| 0.8
| 0.7
|
dnr after sadm
| 1
| 69
| 11.599609
| 104
| 24
| 35.5
| 157.125
| 3.899902
| 0.599976
| 1.599854
| 135
| 7.369141
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 58
| 1
|
75.87695
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
|
$25-$50k
| 0
| 4,041
| 3,294.3086
| 2,848.53906
| 17
|
white
| 15
| 35
| 0.881958
| 0.802979
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 1
| 63
| 9.898438
| 73
| 28
| 35.79688
| 295.1875
| 3.899902
| 0.799927
| 1.099854
| 140
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 977
| 1
|
64.45996
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 10,293
| 7,336.9844
| 7,129.15625
| 11.5
|
white
| 19.398438
| 20
| 0.840942
| 0.738892
| 1
| 0
| 0
|
yes
| 0.75
| 0.75
|
no dnr
| 12
| 87
| 34.398438
| 132
| 24
| 38.29688
| 285.125
| 4.099609
| 0.799927
| 0.699951
| 134
| 7.419922
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,179
| 1
|
60.42999
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,457
| 2,783.0488
| 2,312.45898
| 15
|
white
| 7.599609
| 11
| 0.85791
| 0.68396
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 72
| 3.5
| 70
| 20
| 36.19531
| null | 4.199219
| 0.399963
| 0.799927
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.710938
| 1,513
| 1
|
67.16498
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 5,430
| 4,154.957
| 3,476.1582
| 8
|
white
| 24.097656
| 36
| 0.757935
| 0.615967
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 8
| 101
| 21
| 120
| 24
| 35.69531
| 209.0625
| null | null | 1.099854
| 138
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 898
| 1
|
52.95798
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 9
|
under $11k
| 0
| 2,227
| 1,943.7852
| 1,477.59961
| 10
|
white
| 14.798828
| 16
| 0.773926
| 0.529907
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 5
| 107
| 7.799805
| 77
| 24
| 36.79688
| null | null | null | 1.399902
| 136
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 686
| 1
|
82.57898
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 16
| null | 0
| 2,881
| 2,437.209
| 1,677.16992
| 10
|
white
| 20.398438
| 23
| 0.748901
| 0.60498
| 1
| 1
| 0
|
yes
| 1
| 1
|
no dnr
| 6
| 106
| 10.599609
| 54
| 24
| 35.59375
| 342.8125
| null | null | 1.199951
| 135
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,572
| 0
|
54.883
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 15,018
| 10,734.4688
| 10,703.6641
| 19
|
white
| 22.898438
| 40
| 0.859985
| 0.768921
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 58
| 8.699219
| 50
| 22
| 36.39844
| null | 4.099609
| 0.599976
| 2.599609
| 130
| null | null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 296
| 1
|
70.57098
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 7
|
under $11k
| 0
| 3,154
| 2,479.1641
| 2,328.84961
| 6
|
white
| 3.099609
| 23
| 0.888916
| 0.746948
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 6
| 69
| 6
| 81
| 24
| 36.59375
| null | 4.399414
| 0.399963
| 1.099854
| 142
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.677246
| 254
| 1
|
82.06696
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 8
| null | 0
| 3,685
| 3,021.3086
| 2,684.58984
| 8
|
white
| 14.099609
| 26
| 0.725952
| 0.451965
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 6
| 77
| 6.099609
| 77
| 22
| 35.59375
| null | 3.699707
| 0.399963
| 1.099854
| 134
| null | null | null | null | 0
| null | null | 0.4948
| 356
| 1
|
68.17798
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 3
| 12
|
$25-$50k
| 0
| 3,745
| 2,759.084
| 2,308.72852
| 10
|
white
| 18.199219
| 13
| 0.793945
| 0.564941
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 92
| null | 56
| 20
| 35.59375
| null | null | null | null | 140
| null | null | null | null | 0
| 1
| null | 1
| 101
| 1
|
84.03796
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 12
| null | 0
| 5,013
| 3,908.5117
| 3,510.07812
| 14.5
|
white
| 15.5
| 41
| 0.822998
| 0.711914
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 1
| 59
| 11.898438
| 69
| 26
| 36.19531
| 268
| 3.899902
| 0.299988
| 1
| 137
| 7.379883
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,566
| 0
|
66.31299
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 14,233
| 11,140.5781
| 9,157.45312
| 13
|
white
| 21.199219
| 19
| 0.800903
| 0.678955
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 62
| null | 105
| 20
| 38
| 145
| null | null | 1.199951
| 135
| 7.429688
| null | null | null | 0
| 3
|
no(M2 and SIP pres)
| 3
| 1,566
| 0
|
58.883
|
male
| 1
| 4
|
Coma
|
Coma
| 0
| 6
|
$11-$25k
| 100
| 10,109
| 6,643.3828
| 7,060.84766
| 27
|
white
| 27.097656
| 45
| 0.182983
| 0.125977
| 1
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 1
| 167
| 15.599609
| 182
| 8
| 39
| 164
| 4.599609
| 0.399963
| 0.799927
| 155
| 7.569336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
81.88397
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
| null | 0
| 2,367
| 1,813.1553
| 1,324.67969
| 6
|
hispanic
| 16.699219
| 35
| 0.846924
| 0.748901
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 4
| 61
| 4.599609
| 80
| 28
| 36
| 252.375
| null | null | 1.099854
| 136
| 7.519531
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.143066
| 1,045
| 1
|
70.034
|
male
| 0
| 32
|
Coma
|
Coma
| 0
| 16
|
>$50k
| 44
| 36,490
| 25,928.2812
| 25,123.3438
| 18.5
|
white
| 23
| 18
| 0.471985
| 0.399963
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 32
| 133
| 18.796875
| 106
| 10
| 38.09375
| 140
| null | null | 1
| 143
| 7.529297
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,566
| 0
|
45.06497
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 9,426
| 7,679.543
| 6,140.44922
| 9
|
white
| 17.898438
| 17
| 0.922974
| 0.868896
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 74
| 10.5
| 126
| 20
| 35.59375
| null | 4.299805
| 1.299805
| 1.099854
| 139
| null | null | null | null | 0
| null | null | 0.4948
| 1,564
| 0
|
81.85394
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
|
$11-$25k
| 0
| 6,725
| 5,676.6602
| 4,296.05859
| 7.5
|
white
| 17.398438
| 32
| 0.838989
| 0.736938
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 13
| 112
| 7.899414
| 76
| 20
| 36.19531
| 238.09375
| 3.699707
| 0.799927
| 1.799805
| 133
| 7.509766
| null | null | null | 5
| 5
|
SIP>=30
| 5
| 1,083
| 1
|
61.71399
|
female
| 0
| 41
|
Coma
|
Coma
| 0
| 12
| null | 61
| 57,452
| 48,214.875
| 45,286.1875
| 30.25
|
white
| 16.796875
| 21
| 0.632935
| 0.571899
| 1
| 0
| 0
|
no
| 1
| 0.99
|
no dnr
| 41
| 123
| 19.296875
| 68
| 8
| 38
| 210
| 4.799805
| 0.899902
| 1.099854
| 147
| 7.439453
| null | null | null | null | 0
| null | 0
| 65
| 1
|
71.461
|
female
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
| null | 0
| 43,218
| 32,969
| 26,999.2969
| 18.75
|
white
| 33.59375
| 59
| 0.509888
| 0.392944
| 1
| 1
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 42
| 68
| 28
| 134
| 28
| 35.19531
| null | 3.199707
| 0.5
| 5.899414
| 132
| null | null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 1,562
| 0
|
80.84094
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 17,250
| 12,146.3047
| 10,440.8125
| 19.5
|
white
| 16.597656
| 23
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 13
| 63
| 6
| 52
| 20
| 36.69531
| null | null | null | 1.199951
| 141
| null | null | null | null | null | null | null | 3.058594
| 1,563
| 0
|
71.58099
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 9
|
$11-$25k
| 0
| 1,985
| 1,450.2559
| 1,251.7793
| 7
|
white
| 16
| 20
| 0.711914
| 0.430969
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 3
| 117
| 5.5
| 62
| 24
| 36.09375
| null | 3.599609
| 0.5
| 1.5
| 139
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.019043
| 1,560
| 0
|
59.49298
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 2,963
| 2,366.2129
| 1,990.06934
| 9
|
white
| 24.898438
| 19
| 0.53894
| 0.215973
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 1
| 73
| 40
| 101
| 20
| 36
| 338.0625
| null | 0.599976
| 0.799927
| 130
| 7.40918
| null | null | null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 59
| 1
|
74.55695
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
| null | 0
| 2,100
| 1,671.5469
| 1,479.7793
| 18
|
white
| 9.898438
| 26
| 0.914917
| 0.855957
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 3
| 71
| 9.298828
| 60
| 20
| 36.19531
| 376.1875
| 4.799805
| 0.5
| 1.299805
| 141
| 7.459961
| null | null | null | null | null | null | 2.165039
| 1,560
| 0
|
70.11096
|
male
| 1
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 10,505
| 7,555.5586
| 6,805.32812
| 26.5
|
white
| 19.398438
| 45
| 0.8479
| 0.75
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
dnr after sadm
| 9
| 105
| 36.398438
| 110
| 36
| 38.29688
| 242.84375
| 4
| 0.399963
| 1.399902
| 136
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.825684
| 10
| 1
|
58.71899
|
male
| 0
| 343
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$25-$50k
| 0
| 556,878
| 463,230
| 409,602
| 47.75
|
white
| 45.695313
| 66
| 0.221985
| 0.123993
| 13
| 0
| 0
|
no
| null | null |
dnr after sadm
| 45
| 53
| 20.699219
| 124
| 34
| 39.19531
| 62.10156
| null | null | 4.399414
| 153
| 7.25
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,558
| 0
|
63.16498
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 2,532
| 2,167.4883
| 1,894.41992
| 9
|
white
| 19.5
| 21
| 0.660889
| 0.358948
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 6
| 73
| 2
| 107
| 16
| 37.89844
| null | null | null | 1
| 129
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.09668
| 556
| 1
|
79.77496
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 3,239
| 2,465.4785
| 2,160.48828
| 16
|
white
| 16.296875
| 27
| 0.835938
| 0.731934
| 1
| 0
| 0
|
no
| 0.99
| 0.8
|
no dnr
| 5
| 93
| 7.399414
| 71
| 22
| 36.09375
| 190.46875
| 3.599609
| 0.299988
| 1.199951
| 137
| 7.439453
| null | null | null | null | null | null | 2.457031
| 1,555
| 0
|
63.48297
|
male
| 0
| 116
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 37
| 101,761
| 154,723.125
| 129,909.062
| 27.5
|
white
| 36
| 47
| 0.287964
| 0.177979
| 10
| 1
| 0
|
no
| 0.8
| 0.9
|
no dnr
| 116
| 100
| 15.199219
| 116
| 12
| 39.69531
| 212.5
| 3.399902
| 7.699219
| 4.199219
| 150
| 7.399414
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 618
| 1
|
88.11499
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 5
| null | 0
| 7,987
| 6,105.9609
| 4,972.75
| 14
|
white
| 21.097656
| 36
| 0.702881
| 0.539917
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 105
| 11.298828
| 100
| 36
| 36.19531
| 159.15625
| 4.399414
| 0.399963
| 1.699951
| 142
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,347
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.